PTPRC and cancer: In a multivariate analysis of recurrence-free survival, TRG was not significantly associated with recurrence-free survival; however, advanced yStage (III-IV) and high CD45 expression in cancer cells were significantly associated with shorter recurrence-free survival (Figure 2B, upper panel).